10x Genomics, Inc. Research and Development in Process
10x Genomics, Inc. (TXG) reported Research and Development in Process of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-02-16
- 10x Genomics, Inc. research and development in process for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- 10x Genomics, Inc. research and development in process for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- 10x Genomics, Inc. research and development in process for the quarter ending 2020-12-31 was $406.91M.
- 10x Genomics, Inc. research and development in process for the quarter ending 2020-09-30 was $40.64M.
- 10x Genomics, Inc. research and development in process for fiscal 2022 was $0.00.
- 10x Genomics, Inc. research and development in process for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- 10x Genomics, Inc. research and development in process for fiscal 2020 was $447.55M.
- 10x Genomics, Inc. research and development in process for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-16 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $0.00 derived: sum of 2 quarters · filed 2023-02-16 | $0.00 10-K · filed 2023-02-16 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 | ||
| 2020-12-31 | $406.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $447.55M derived: sum of 2 quarters · filed 2023-02-16 | $447.55M 10-K · filed 2023-02-16 | |
| 2020-09-30 | $40.64M 10-Q · filed 2021-11-05 | $40.64M 10-Q · filed 2021-11-05 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $0.00 derived: sum of 2 quarters · filed 2022-02-18 | $0.00 10-K · filed 2022-02-18 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | $40.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $56.16M derived: sum of 2 quarters · filed 2021-02-26 | $62.36M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $16.10M 10-Q · filed 2019-11-12 | $22.31M 10-Q · filed 2019-11-12 |